Denver, Colorado-based DaVita Inc. (DVA) provides dialysis services to patients with chronic kidney failure in the United States. The company has a market cap of $13.3 billion and operates kidney dialysis centers and provides related lab services in outpatient dialysis centers.
Companies with a market cap of $10 billion or more are typically referred to as “big-cap stocks.” DVA fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size and influence in the medical care facilities industry.